Tom Willis

Direttore/Membro del Consiglio presso Cernostics, Inc.

Health Technology

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Rebecca Critchley-Thorne	M	-	Cernostics, Inc. Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.	16 anni
Mike Hoerres	M	-	Cernostics, Inc. Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.	-
Noel Thomas Doheny	M	-	Cernostics, Inc. Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.	-
Ephraim F. Gildor	M	-	Cernostics, Inc. Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.	-
Gregg Fergus	M	-	Cernostics, Inc. Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.	-
John Inadomi	M	-	Cernostics, Inc. Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.	-
Nicholas Shaheen	M	-	Cernostics, Inc. Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.	-